Skip to main content
Premium Trial:

Request an Annual Quote

China Medical Technologies Receives SFDA Approval for HPV Chip

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies said today it has received approval of its surface plasmon resonance-based HPV-DNA chip from the State Food and Drug Administration of China.

The chip can detect high-risk and low-risk genotypes by analyzing a patient sample on the company's fully automated SPR analyzer, Beijing-based China Medical Technologies said in a statement. It added that the chip can distinguish multiple human papillomavirus infections and determine the viral load.

According to the World Health Organization, China has about 500 million women ages 15 and up who are at risk for cervical cancer, the company said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.